Skip to content

Evaluation of the efficacy of phenol use in the sensory pathways of the hip, guided by ultrasonography, for the relief of chronic pain in patients with advanced arthrosis

The effectiveness of US-guided phenol block of the articular sensory branches of the obturator and femoral nerves for the relief of chronic pain in advanced osteoarthritis of the hip - A prospective study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-667rhb
Enrollment
Unknown
Registered
2019-06-10
Start date
2019-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

Experimental Group: 15 patients with advanced hip osteoarthrosis (grade 3 or 4 according to the Kellgren-Lawrence scale), with chronic pain (more than 3 months) of intensity greater than 4 (on a scale
Other

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals over 18 years of age; clinical and radiological diagnosis compatible with advanced hip osteoarthritis; pain greater than or equal to 4 on a numerical scale of 0 to 10 (where zero means absence of pain and 10 the most intense pain imagined); chronic pain (more than 3 months)

Exclusion criteria

Exclusion criteria: Cognitive impairment or psychiatric disease; infection; coagulopathy; previous hip surgery; local deformities; other potential causes of pain referred to the hip region but not related to femoroacetabular osteoarthrosis

Design outcomes

Primary

MeasureTime frame
Reduction of at least 30% in the pain scores assessed by visual numerical pain scale after the procedure.

Secondary

MeasureTime frame
Functional improvement assessed through an increase in joint range of motion after the procedure.

Countries

Brazil

Contacts

Public ContactVanessa Moreira Lima Finato

Universidade Federal de São Paulo

vanessafinato@gmail.com+551155764848

Outcome results

None listed

Source: REBEC (via WHO ICTRP)